Skip to content

REGENXBIO Inc.

RGNX

CIK 0001590877

← back to feed
Revenue (TTM)
$146.5M
+104.5% YoY Q1 May 2026
Net Income (TTM)
−$216.78M
+14.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$4.18
+18.1% YoY Q1 May 2026
Gross Margin
72.9%
Q1 May 2026
Operating Margin
-127.6%
Q1 May 2026
Net Margin
-148.0%
Q1 May 2026
Free Cash Flow (TTM)
−$186.56M
Q1 May 2026
Cash
$15.23M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
51.7M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings